• 제목/요약/키워드: Parenteral

검색결과 288건 처리시간 0.032초

Management of malaria in Thailand

  • Silachamroon, Udomsak;Krudsood, Srivicha;Phophak, Nanthaphorn;Looareesuwan, Sornchai
    • Parasites, Hosts and Diseases
    • /
    • 제40권1호
    • /
    • pp.1-7
    • /
    • 2002
  • The purpose of treatment for uncomplicated malaria is to produce a radical cute using the combination of: artesunate (4 mg/kg/day) plus mefloquine (8 mg/kg/day) for 3 days; a fixed dose of artemether and lumefantrine (20/120 mg tablet) named $Coartem^{\circledR}$ (4 tablets twice a day for three days for adults weighing more than 35 kg); quinine 10 mg/kg 8-hourly plus tetracycline 250 mg 6-hourly for 7 days (or doxycycline 200 mg as an alternative to tetracycline once a day for 7 days) in patients aged 8 years and over; $Malarone^{\circledR}$ (in adult 4 tablets daily for 3 days). In treating severe malaria, early diagnosis and treatment with a potent antimalarial drug is recommended to save the patient's life. The antimalarial drugs of choice are: intravenous quinine or a parenteral form of an artemisinin derivative (artesunate i.v./i.m. for 2.4 mg/kg followed by 1.2 mg/kg injection at 12 and 24 hr and then daily for 5 days; artemether i.m. 3.2 mg/kg injection followed by 1.6 mg/kg at 12 and 24 hrs and then dialy for 5 days; arteether i. m. ($Artemotil^{\circledR}$) with the same dose of artemether or artesunate suppository (5 mg/kg) given rectally 12 hourly for 3 days. Oral arlemisinin derivatives (artesunate, artemether, and dihydroartemisinin with 4 mg/kg/day) could replace parenteral forms when patients can tolerate oral medication. Oral mefloquine (25 mg/kg divided into two doses 8 hrs apart) should be given at the end of the artemisinin treatment course to reduce recrudescence.

Nitrous Oxide를 이용한 흡입진정 (Inhalation Sedation with Nitrous Oxide in Dental Treatment)

  • 윤형배
    • 대한치과마취과학회지
    • /
    • 제2권1호
    • /
    • pp.1-6
    • /
    • 2002
  • The usage of nitrous oxide is increased for the anxious patient to dental treatment. There are two methods to induce the sedation during dental treatment. One is sedation with drugs the other no need of drugs. We discussed here about sedation with drugs. The methods of drug administration are oral, intramuscular, intravenous, inhalation. The method of oral administration of drugs are convenient to patient and doctor but poor controllability. Intramuscular method is a parenteral technique that maintains several advantages over the enteral technique. However its pales in comparison to other parenteral technique. Intravenous method represents most effective method of ensuring predictable and adequate sedation in all patients. But it has inability to reverse the action of drugs after they have been injected except some drugs (e.g., narcotics and benzodiazepine). A variety of gaseous agents may be administered by inhalation to produce sedation. In dental practice, the inhalation administration of gas means use of nitrous oxide. There are many advantages of nitrous oxide administration. First, very short latent period and rapid onset of drug action which lead to possible titration of drug concentration. With nitrous oxide, clinical effects may become noticeable as quickly as 15 to 30 seconds after inhalation. Recovery from inhalation sedation is also quite rapid. In out patient dental practice rapid recovery is very important because it permit to discharge the patient without escort and the patient return to their ordinary life without limit. To success the conscious sedation with nitrous oxide, the administrator should be keep the mind that always titration of nitrous oxide concentration during induction and treatment. Careful observation need during treatment to prevent oversedation because the adequate nitrous oxide concentration to patients changed by environmental stress. Always begins with 100% oxygen and ends with 100% oxygen to prevent diffusion hypoxia which rare in clinical practice.

  • PDF

Modification of nutrition strategy for improvement of postnatal growth in very low birth weight infants

  • Choi, Ah Young;Lee, Yong Wook;Chang, Mea-young
    • Clinical and Experimental Pediatrics
    • /
    • 제59권4호
    • /
    • pp.165-173
    • /
    • 2016
  • Purpose: To identify the effects of modified parenteral nutrition (PN) and enteral nutrition (EN) regimens on the growth of very low birth weight (VLBW) infants. Methods: The study included VLBW infants weighing <1,500 g, admitted to Chungnam National University Hospital between October 2010 and April 2014, who were alive at the time of discharge. Subjects were divided according to 3 periods: period 1 (n=37); prior to the PN and EN regimen being modified, period 2 (n=50); following the PN-only regimen modification, period 3 (n=37); following both PN and EN regimen modification. The modified PN regimen provided 3 g/kg/day of protein and 1 g/kg/day of lipid on the first day of life. The modified EN regimen provided 3.5-4.5 g/kg/day of protein and 150 kcal/kg/day of energy. We investigated growth rate, anthropometric measurements at 40 weeks postconceptional age (PCA) and the incidence of extrauterine growth restriction (EUGR) at 40 weeks PCA. Results: Across the 3 periods, clinical characteristics, including gestational age, anthropometric measurements at birth, multiple births, sex, Apgar score, surfactant use and PDA treatment, were similar. Growth rates for weight and height, from time of full enteral feeding to 40 weeks PCA, were higher in period 3. Anthropometric measurements at 40 weeks PCA were greatest in period 3. Incidence of weight, height and head circumference EUGR at 40 weeks PCA decreased in period 3. Conclusion: Beginning PN earlier, with a greater supply of protein and energy during PN and EN, is advantageous for postnatal growth in VLBW infants.

비화음으로 호전된 기능성 소화불량 환자 치험 1례 (A Case Report of Functional Dyspepsia Treated with Beewha-eum)

  • 박채현;김민정;박재우;고석재
    • 대한한방내과학회지
    • /
    • 제45권2호
    • /
    • pp.159-166
    • /
    • 2024
  • Objective: The purpose of this case study is to report the effectiveness of the Korean medicine Beewha-eum as a treatment for functional dyspepsia (FD). Methods: A patient diagnosed with a spleen-stomach deficiency-cold pattern in Korean medicine was treated with herbal medicines, including Beewha-eum. Symptom severity was assessed using the degree of self-reported dyspepsia (%), self-reported energy level, amount of food intake (%), total parenteral nutrition rate (cc/hour), body weight (kg), Nepean dyspepsia index (NDI-K), functional dyspepsia-related quality of life questionnaire (FD-QoL), and short form 36-item health survey (SF-36) score. Results: After treatment, the symptom severity of self-reported dyspepsia decreased from 100% to 10 to 15%, and the self-reported energy level increased from 20 to 80. The amount of food intake increased from 5% to 100%, and the total parenteral nutrition rate started from 60 cc/hour end in week 5. Body weight increased from 53.1 kg to 62 kg. The NDI-K score decreased from 105 to 31. The FD-QoL score increased from 19 to 68. The SF-36 score also increased from 102 to 116. Conclusion: The results suggest that the Korean medicine Beewha-eum could be an effective option for treating FD.

총정맥영양 연관 담즙정체증 (Comparison of total parenteral nutrition-associated cholestasis according to amino acid mixtures in very low birth weight infants)

  • 최진성;배윤진;이영아
    • Clinical and Experimental Pediatrics
    • /
    • 제49권9호
    • /
    • pp.972-976
    • /
    • 2006
  • 목 적 : 극소 저출생 체중아에서 총정맥영양에 의한 담즙정체는 중요한 합병증 중 하나이다. 총정맥영양에 의한 담즙정체에 영양을 미치는 인자들은 여러 가지가 있으며, 그중 아미노산의 조성이 총정맥영양을 시행 받은 극소 저출생 체중아의 담즙정체 발생에 영향을 주는지 알아보고자 하였다. 방 법 : 2000년 1월부터 2004년 12월까지 동아대학교의료원 신생아 중환자실에 입원한 극소 저출생 체중아 중에서 일주일이상 총정맥영양을 시행 받은 환아 63명을 연구대상으로 하였다. 2000년 1월부터 2002년 6월까지의 연구 대상을 제1군으로, 2002년 7월부터 2004년 12월까지의 연구대상은 제1군과는 cysteine, tyrosine, taurine, glutamate 등의 성분이 차이가 있는 아미노산 제제를 사용하여 제2군으로 분류하였다. 제1군과 제2군의 임상적 특징과 총정맥영양에 의한 담즙정체의 빈도를 비교하였다. 결 과 : 제1군(n=32)과 제2군(n=31)의 재태연령($29.7{\pm}2.7$주, $29.5{\pm}2.8$주), 출생체중($1,195.6{\pm}200.4g$, $1,177.0{\pm}224.0g$) 및 총정맥영양 시작시기($16.1{\pm}8.5$일, $14.8{\pm}7.7$일), 총정맥영양의 기간($25.7{\pm}13.5$일, $25.4{\pm}12.1$일), 제공된 아미노산의 양($1.45{\pm}0.49$g/kg/일, $1.65{\pm}0.89$ g/kg/일), 완전장관영양 도달시기($59.9{\pm}23.2$일, $61.0{\pm}18.0$ 일)에는 유의한 차이가 없었다. 총정맥영양과 관련된 담즙정체의 빈도는 제1군은 7례(21.9%), 제2군은 2례(6.5 %)로 제2군에서 감소되는 경향을 보였으나 통계학적 의미는 없었다(P=0.148). 두 군 간의 최고 직접 빌리루빈 수치($1.62{\pm}1.18mg/dL$, $1.04{\pm}1.05mg/dL$, P=0.046)와 평균 직접 빌리루빈 수치($0.78{\pm}0.46mg/dL$, $0.52{\pm}0.29mg/dL$, P=0.012)는 각각 제2군에서 의미 있게 낮았다. 결 론 : 총정맥영양을 시행 받은 극소 저출생 체중아에서 생기는 총정맥영양에 관련된 담즙정체를 비교한 결과, 아미노산 조성의 차이에 따라 담즙정체의 발생 빈도에 차이가 있었으나 통계학적 유의성은 없었고, 직접 빌리루빈 수치는 의미 있게 감소하였다. 그러나 좀 더 많은 연구 대상을 통한 연구가 필요하리라 생각한다.

정맥영양 극소저체중출생아의 간담도 기능 이상 (Hepatobiliary Dysfunction in Very Low Birth Weight Infants Supported with Parenteral Nutrition)

  • 이윤희;빈중현;이주영;이현승;이정현;김소영;성인경;전정식
    • Neonatal Medicine
    • /
    • 제16권2호
    • /
    • pp.197-204
    • /
    • 2009
  • 목 적 : 동일 병원에서 같은 기준에 의하여 정맥영양을 받는 미숙아들 중에도 간기능 검사 결과는 쓸개즙정체가 있는 경우와 없는 경우, 간효소의 수치만 오르고 쓸개즙정체의 증상이 없는 경우, 쓸개즙정체 및 간효소 수치의 이상이 없는 경우 등 서로 다른 것을 알 수 있다. 저자들은 출생 직후부터 정맥영양을 받은 미숙아 및 극소저출생체중아들을 대상으로 간기능 검사 결과의 양상 및 이에 영향을 미치는 요인을 알아보기 위하여 본 연구를 시행하였다. 방 법 : 2004년 1월 1일부터 2008년 12월 31일까지 가톨릭의대 부천 성모병원 신생아 집중치료실에 입원했던 출생체중 1,500 gm 미만의 미숙아들 중 2주 이상 TPN을 시행한 92명을 대상으로 이들의 의무 기록지를 후향적으로 검토하였다. 정맥영양 시행 2주 이후부터 관찰기간 동안 시행된 대상아 각각의 간기능 검사 전체를 분석하였으며 검사 결과 혈청 직접빌리루빈(direct bilirubin, DB) 2 mg/dL 이상이 측정되었고 담도폐쇄나 쓸개즙정체를 초래할 다른 원인이 배제된 경우 쓸개즙정체 그룹으로, aspartate aminotransferase (AST) 및 alanine aminotransferase (ALT)가 각각 60 IU/L 이상으로 측정되었고 측정시기에 상기의 제외기준을 비롯하여 뚜렷한 간손상의 원인을 알 수 없었던 경우 간세포손상 그룹으로 하였다. DB 2 mg/dL 이상인 쓸개즙정체그룹을 I군, DB 2 mg/dL 미만이나 AST 및 ALT가 각각 60 IU/L 이상인 간효소치 이상군을 II군, 각각에 이상이 없었던 정상군을 III군으로 하였다. 각 대상아들의 출생체중, 재태주령, 분만방법, 당뇨병 및 전자간증 등의 산모질환, 1분 및 5분 아프가 점수, 계면활성제 사용, 장관영양 시작 시기, 정맥영양기간, 적혈구수혈 횟수, 패혈증, 괴사성장염, 만성호흡곤란증, 동맥관개존증 발생 등을 비교하였다. 결 과 : 대상아들 중 쓸개즙정체 그룹이 36명(39.1%), 간세포손상 그룹이 51명(55.4%) 이었으며, I군 36명(39.1%), II군 19명(20.7%), III군 37명(40.2%) 이었다. 쓸개즙정체그룹과 간세포손상 그룹 각각에 대한 T검정 및 교차분석 결과 재태일령, 출생체중, 1분 및 5분 아프가 점수, 정맥영양기간, 적혈구수혈 횟수, 계면활성제 사용, BPD 진단, PDA 진단 유무에서 유의한 상관관계를 보였다(P<0.05). 쓸개즙정체 그룹을 종속변수로 한 다중회귀분석결과 재태주령, 계면활성제 사용, 패혈증, 적혈구수혈 횟수, 동맥관 개존증과의 관계가 유의했다(P<0.05). 결 론 : 정맥영양을 받고 있는 극소저출생체중아의 쓸개즙정체증에 대하여 정맥영양 이외에 출생체중, 재태주령, 1분 및 5분 아프가 점수, 계면활성제사용, 적혈구수혈 횟수, 만성호흡곤란증, 동맥관개존증 등 요인들에 대한 고민이 동반 되어야 할 것으로 생각된다.

How to Manage the Pediatric Nutritional Support Team: Updates

  • Yang, Hye Ran
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제15권2호
    • /
    • pp.79-84
    • /
    • 2012
  • Pediatric patients in hospital are at risk of malnutrition at admission and even during their hospitalization. Although the concept of nutritional support team (NST) was introduced to hospitals for optimal nutritional care since 1960s and the benefits of pediatric NST have been proven by many studies and reports in terms of patient clinical outcome and cost saving, the pediatric NST is not widespread yet. The pediatric NST composed of pediatricians, dieticians, pharmacist, and nutrition support nurses as core members dedicated to nutritional care in children should be independent of central NST or other disciplines, but closely cooperate with other teams in hospitals. There is no doubt that a multidisciplinary NST is an effective way to provide appropriate nutritional support to an individual patient. Therefore, the implementation of the pediatric NST in hospitals should be recommended to provide optimum nutritional support including enteral tube feeding and parenteral nutrition and to assess pediatric patients at risk of malnutrition.

랫드 및 마우스에서 DWC-751의 급성정맥 및 경구 독성시험 (Acute Intravenous and Oral Toxicity of DWC-751 in Rats and Mice)

  • 김재현;박창원;강진석;유영효;박정식
    • Toxicological Research
    • /
    • 제11권1호
    • /
    • pp.109-116
    • /
    • 1995
  • Single intravenous and oral administration to SD rats and ICR mice of both sexes were performed to investigate the acute toxicity of DWC-751, a new parenteral cephalosporin. $LD_50$ values for ICR mice and SD rats administered intravenously with DWC-751 were as follows; 1151.1 mg/kg (male SD rat), 1183.5 mg/kg (female SD rat), 2698.1 mg/kg (male ICR mouse), 2833.0 mg/kg (female ICR mouse). It is suggested that $LD_50$ values in rats and mice of both sexes would be 5000 mg/kg in oral route. Major general symptoms induced by injection intravenously with DWC-751 are decreased motor activity, increased respiratory rate, tremor and convulsion. In oral route, piloerection and soft stool are observed to 4 day after administration. No significant body weight changes were observed at any level in the groups administered with DWC-751. The gross finding of rats administered intravenously was observed cecum distension.

  • PDF

대동맥-양측대퇴동맥 우회술 후 발생한 유미 복수 (Chylous Ascites After Aorto-Bifemoral bypass Graft)

  • 조규철;김동원;유세영
    • Journal of Chest Surgery
    • /
    • 제27권9호
    • /
    • pp.798-800
    • /
    • 1994
  • Chyloascities is an extravasation of milky chyle into the peritoneal cavity due to tumor , inflammation or rarely postoperative lymphatic trauma.It is an unusual complication that can lead to significant immunologic and nutritional consequences.We experienced one case of chyloascites after aorto-bifemoral bypass graft in a patient with aorto-iliac occlusive disease.The patient was a 62-year-old male, who suffered from severe progressive claudication for 5 months. A 16$\times$ 8mm gelsealed Dacron-Y shaped graft was used in arterial reconstruction. A bloody-milky fluid was drained through the operative wound from 3days after operation and evaluated biochemically.Diagnosis of chyloascites was made with repeated paracentesis and examination of the fluid.After Total parenteral nutrition[T.P.N] for 3 weeks from 6days after operation, chyloascites was controlled sufficiently and maintained a good graft-patency in abdominal sonogram.

  • PDF

히드로겔을 이용한 약물수송시스템 (Hydrogels for Drug Delivery System:-Colon-Specific Delivery-)

  • 박기동;정서영;김영하
    • Journal of Pharmaceutical Investigation
    • /
    • 제22권4호
    • /
    • pp.251-266
    • /
    • 1992
  • A major problem with the peptide-based drugs is that these drugs must generally be administered by injection. Therefore, there is considerable research interest in alternative routes of delivery, such as buccal, nasal, gastrointestinal route and etc. Site-specific drug delivery to the colon, as an alternative to parenteral drug delivery, is of interest for the delivery of peptide-based drugs as well as the delivery of low molecular weight drugs for the treatment of colonic disease, This review describes some considerations of colon-specific drug delivery using hydrogels.

  • PDF